Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C

NCT00951223 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of Enrollment

Conditions

Hepatitis C

Interventions

DRUG: Infergen® (Interferon alfacon-1)

Sponsor

Kadmon Corporation, LLC